QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF - XPH Stock Forecast, Price & News

$43.73
-0.08 (-0.18%)
(As of 02/6/2023 05:20 PM ET)
Add
Today's Range
$43.69
▼
$44.31
50-Day Range
$40.06
▼
$44.25
52-Week Range
$37.94
▼
$46.61
Volume
45,446 shs
Average Volume
38,677 shs
Market Capitalization
$212.09 million
P/E Ratio
N/A
Dividend Yield
1.55%
Price Target
N/A
Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer SSgA
Fund NameSPDR S&P Pharmaceuticals ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:XPH
Inception Date6/19/2006
Fund ManagerMichael Feehily, Karl Schneider, Keith Richardson
Webwww.spdrs.com
Phone+1-617-6644738

Fund Focus

Asset ClassEquity
BenchmarkS&P Pharmaceuticals Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$210.27 million
Average Daily Volume$39,320.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerCitadel

Geographic Exposure of XPH

Currency Exposure of XPH

Sector Exposure of XPH

Industry Exposure of XPH

Key Executives

  • James E. Ross (Age 52)
    President, Trustee
  • Peter A. Ambrosini (Age 69)
    Chief Compliance Officer
  • Michael P. Riley (Age 44)
    Vice President
  • Gary L. French (Age 64)
    Treasurer
  • John W. Clark (Age 46)
    Assistant Treasurer
  • Matthew W. Flaherty (Age 42)
    Assistant Treasurer
  • Chad C. Hallett (Age 47)
    Assistant Treasurer of Street tracks series trust
  • Mary Moran Zeven (Age 52)
    Secretary
  • Scott M. Zoltowski (Age 44)
    Assistant Secretary
  • Dave Kelly
    Independent Trustee

Insiders & Institutions

View All Institutional Transactions













XPH Stock - Frequently Asked Questions

How have XPH shares performed in 2023?

SPDR S&P Pharmaceuticals ETF's stock was trading at $40.95 at the beginning of the year. Since then, XPH stock has increased by 6.8% and is now trading at $43.73.
View the best growth stocks for 2023 here.

Is SPDR S&P Pharmaceuticals ETF a good dividend stock?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) pays an annual dividend of $0.67 per share and currently has a dividend yield of 1.55%.
Read our dividend analysis for XPH.

What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Micron Technology (MU), Broadcom (AVGO), Chevron (CVX), DocuSign (DOCU), SPDR Gold Shares (GLD), International Business Machines (IBM), JPMorgan Chase & Co. (JPM) and AT&T (T).

What is SPDR S&P Pharmaceuticals ETF's stock symbol?

SPDR S&P Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XPH."

Who are SPDR S&P Pharmaceuticals ETF's major shareholders?

SPDR S&P Pharmaceuticals ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include First Citizens Bank & Trust Co. (0.73%), Bank of Montreal Can (0.36%), AE Wealth Management LLC (0.34%), Alta Wealth Advisors LLC (0.14%), Fragasso Group Inc. (0.13%) and U.S. Capital Wealth Advisors LLC (0.02%).

How do I buy shares of SPDR S&P Pharmaceuticals ETF?

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SPDR S&P Pharmaceuticals ETF's stock price today?

One share of XPH stock can currently be purchased for approximately $43.73.

How much money does SPDR S&P Pharmaceuticals ETF make?

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) has a market capitalization of $212.09 million.

How can I contact SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF's mailing address is State Street Financial Center One Lincoln Street, BOSTON, MA 02111, United States. The official website for the company is www.spdrs.com. The company can be reached via phone at +1-617-6644738.

This page (NYSEARCA:XPH) was last updated on 2/6/2023 by MarketBeat.com Staff